文献詳細
増大特集 認知症の危険因子と防御因子
文献概要
過去数十年にわたり世界的に寿命が延長してきており,わが国を含めた一部の先進国では超高齢社会を迎えている。こうした高齢化に伴い,認知症をはじめとした加齢性疾患発症も増加している。近年のさまざまな臨床研究により,認知症は心血管疾患,とりわけ高血圧や心房細動と関連があることが示されてきている。本項ではこうした高血圧や心房細動と認知症発症に関するエビデンスを紹介していく。
参考文献
1)Debette S, Markus HS: The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 341: c3666, 2010
2)Kuller LH, Lopez OL, Newman A, Beauchamp NJ, Burke G, et al: Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology 22:13-22, 2003
3)van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, et al: Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 39: 2712-2719, 2008
4)Qiu C, Winblad B, Fratiglioni L: The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4: 487-499, 2005
5)Staessen JA, Richart T, Birkenhäger WH: Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertension 49: 389-400, 2007
6)Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K: Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64: 277-281, 2005
7)Launer LJ, Ross GW, Petrovitch, Masaki K, Foley D, et al: Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 21: 49-55, 2000
8)Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, et al: Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322: 1447-1451, 2001
9)Wu C, Zhou D, Wen C, Zhang L, Como P, et al: Relationship between blood pressure and Alzheimer's disease in Linxian County, China. Life Sci 72: 1125-1133, 2003
10)Qiu C, von Strauss E, Fastbom J, Winblad B, Fratiglioni L: Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Arch Neurol 60: 223-228, 2003
11)Li G, Rhew IC, Shofer JB, Kukull WA, Breitner JC, et al: Age-varying association between blood pressure and risk of dementia in those aged 65 and older: a community-based prospective cohort study. J Am Geriatr Soc 55: 1161-1167, 2007
12)Posner HB, Tang MX, Luchsinger J, Lantigua R, Stern Y, et al: The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 58: 1175-1181, 2002
13)Verghese J, Lipton RB, Hall CB, Kuslansky G, Katz MJ: Low blood pressure and the risk of dementia in very old individuals. Neurology 61: 1667-1672, 2003
14)Morris MC, Scherr PA, Hebert LE, Glynn RJ, Bennett DA, et al: Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol 58: 1640-1646, 2001
15)Ninomiya T, Ohara T, Hirakawa Y, Yoshida D, Doi Y, et al: Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama study. Hypertension 58: 22-28, 2011
16)二宮利治, 清原 裕: 高血圧は認知症発症リスクとなるか. 疫学研究の知見. 認知症の最新医療3: 6-11, 2013
17)Scalco MZ, van Reekum R: Prevention of Alzheimer disease. Encouraging evidence. Can Fam Physician 52: 200-207, 2006
18)Yamada M, Kasagi F, Sasaki H, Masunari N, Mimori Y, et al: Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study. J Am Geriatr Soc 51: 410-414, 2003
19)Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ: The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 274: 1846-1851, 1995
20)Jönsson L, Gerth W, Fastbom J: The potential economic consequences of cognitive improvement with losartan. Blood Press 11: 46-52, 2002
21)Forette F, Seux ML, Staessen JA, Thijs L, Birkenhäger WH, et al: Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352: 1347-1351, 1998
22)Collins R, MacMahon S: Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials. Lancet 357: 373-380, 2001
23)Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, et al: Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 163: 1069-1075, 2003
24)Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, et al: The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 21: 875-886, 2003
25)Peters R, Beckett N, Forette F, Tuomilehto J, Clarke R, et al: Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 7: 683-689, 2008
26)Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, et al: Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination. Int J Cardiol 137: 102-107, 2009
27)Santangeli P, Di Biase L, Bai R, Mohanty S, Pump A, et al: Atrial fibrillation and the risk of incident dementia: a meta-analysis. Heart Rhythm 9: 1761-1768, 2012
28)Marzona l, O'Donnell M, Teo K, Gao P, Anderson C, et al: Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. CMAJ 184: E329-E336, 2012
29)Kalantarian S, Stern TA, Mansour M, Ruskin JN: Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med 158: 338-346, 2013
30)de Bruijn RF, Heeringa J, Wolters FJ, Franco OH, Stricker BH, et al: Association between atrial fibrillation and dementia in the general population. JAMA Neurol 72: 1288-1294, 2015
31)Barnes DE, Yaffe K: The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10: 819-828, 2011
32)World Health Organization and Alzheimer's Disease International: Dementia: a public health priority. World Health Organization, Geneva, 2012
掲載誌情報